Oncology Pharmacy Education Network Webinar Series

As part of American Pharmacists Month, the ACCC Oncology Pharmacy Education Network hosted a four-part webinar series to provide timely education to help elevate the role of pharmacy professionals in the multidisciplinary cancer care team. The on-demand recordings and slides are available for download. 

Pharmacy Metrics for Off-Label Treatment   

Ali McBride, PharmD, MS, BCOP, The University of Arizona Cancer Center (Moderator)
Sarah Hudson-DiSalle, RPH, PharmD, The James Cancer Hospital and Wexner Medical Center, Ohio State University School of Pharmacy
Derek Burns, PharmD, BCPS, DPLA, Rocky Mountain Cancer Centers-Aurora

Pharmacists and Older Adults with Cancer: Effective Practices

Ginah Nightingale, PharmD, BCOP, Thomas Jefferson University Hospitals

Billing for Chemotherapy Patient Management: Extending and Elevating the Pharmacist Role

John Valgus, PharmD, MHA, BCOP, University of North Carolina Medical Center (Moderator)
Sandra Leal, PharmD, MPH, FAPhA, CDCES, SinfoniaRx, a TRHC Solution, Health Plans and Payers Business Unit 
Bhavesh Shah, Boston Medical Center

Closing the Oncology Research Gap: Pharmacy's Role Defined

Sandeep Parsad, PharmD, MBA, BCOP, University Of Chicago Medicine (Moderator)
Sapna R. Amin, PharmD, BCOP, MD Anderson Cancer Center 
Cindy O'Bryant, PharmD, BCOP, FCCP, FHOPA, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Siu Fun Wong, PharmD, UCI HEALTH

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webcast. 

 ACCC thanks Merck & Co. for their financial support of the Oncology Pharmacy Education Network.

You must have an ACCC or state society account to register for this webinar series. 

 If You DO NOT Have an Account: 

  • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page. 
  • ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.  
  • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.  
  • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link. 
  • The green box in the upper right corner of this page will indicate “You are registered!” for this course! 

If You Have an Account: 

  • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button. 
  • You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course! 

PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!  

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar. 

Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar seroes. For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org

Pharmacy Metrics for Off-Label Treatment

image

Ali McBride, PharmD, MS, BCOP (Moderator)

Clinical Coordinator of Hematology/Oncology, The University of Arizona Cancer Center

Ali McBride, PharmD, MS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. Currently serving on the Board of the Association of Community Cancer Centers (ACCC), Dr. McBride also chairs the Awards Selection Committee as well as the Corporate Development Committee. In addition to being a long-time ACCC member, Dr. McBride has been actively involved with the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA).

Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at the U.S. Food and Drug Administration (FDA) Drug Shortage Workshop; presented on behalf of ACCC at the Washington, D.C., Congressional Session; and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacoeconomic impact of biosimilars into the U.S. marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. healthcare market.

image

Sarah Hudson-DiSalle, PharmD, RPH

Oncology Pharmacy Manager, Medication Assistance Program and Reimbursement Services, The James Cancer Hospital and Wexner Medical Center, Ohio State University Department of Pharmacy

Dr. Hudson-DiSalle is the manager in the Medication Assistance Program and Reimbursement Services at the Wexner Medical Center and James Cancer Hospital in Columbus, OH. She is responsible for managing and advocating for the Medication Assistance Program for patients who cannot afford their medications, as well as overseeing reimbursement authorization for off label medication use, high dollar therapy usage, infused medication and medication denials. Dr. Hudson-DiSalle serves on the Board of the Charitable Pharmacy of Central Ohio, the Health Policy Committee of the Hematology/Oncology Pharmacy Association (HOPA), and the Legislative Committee of the Ohio Society of Health System Pharmacists.

image

Derek Burns, PharmD, BCPS, BCSCP, DPLA

Director of Pharmacy & Admixture Services, Rocky Mountain Cancer Centers

Derek M. Burns, PharmD, BCPS, BCSCP, DPLA, is a clinical pharmacist and the pharmacy manager for Rocky Mountain Cancer Centers in Denver, Colorado. Within his current role, Dr. Burns provides oversight of pharmacy services for 13 infusion centers and one of the largest accredited specialty pharmacies within US Oncology. In addition to managing the pharmacy team, he serves as a committee member of the US Oncology Network’s USP 800 and Pharmacy Operations Sub-Committees.  

He is dedicated to improving the standard of pharmacy care through leadership, innovation, safety, and efficiency, while maximizing the value provided to the patient. His vision is to consistently empower teams to optimize performance, cultivate engagement, and to continue rejecting the status quo.

He is highly involved with the Colorado Pharmacy Society as an executive committee member of the Academy of Health-System Pharmacists and serves on its legislative committee. He previously served in a similar capacity for the Montana Pharmacy Association and was nominated as an American Society of Health-System Pharmacists (ASHP) House of Delegates representative.

Dr. Burns earned his Doctor of Pharmacy degree from Butler University in Indianapolis, Indiana. He is board certified in pharmacotherapy and sterile compounding and completed the ASHP Pharmacist Leadership Academy in 2016.

Pharmacists and Older Adults with Cancer: Effective Practices

image

Ginah Nightingale, PharmD, BCOP

Advanced Practice Pharmacist, Thomas Jefferson University Hospitals

Dr. Nightingale is a full-time faculty member in the Department of Pharmacy Practice at the Jefferson College of Pharmacy  for the past eight years in both the didactic and experiential settings. Dr. Nightingale’s clinical practice sites include the inpatient Medical Oncology unit at Thomas Jefferson University Hospital and the ambulatory Senior Adult Oncology Center at Thomas Jefferson University Hospital, Kimmel Cancer Center where she provides medication management services, medication adherence counseling and medication education. 

Dr. Nightingale’s research interests include senior adult oncology, specifically, medication-related problems including polypharmacy, potentially inappropriate medication use, adverse drug events, and medication adherence in senor adults living with cancer. She has authored several papers on the prevalence of polypharmacy in older adults with cancer and the impact of polypharmacy on patient outcomes in older adults with cancer.

Dr. Nightingale is an active member of the Hematology Oncology Pharmacy Association (HOPA), the International Society of Geriatric Oncology (SIOG), and the American Society of Health-System Pharmacists (ASHP). Dr. Nightingale earned her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy, Rutgers University in New Jersey. She is a Board Certified Oncology Pharmacist through the Board of Pharmacy Specialties.

Billing for Chemotherapy Patient Management: Extending and Elevating the Pharmacist Role

image

John Valgus, PharmD, MHA, BCOP (Moderator)

Assistant Director, Department of Pharmacy, University of North Carolina Medical Center

John M. Valgus, PharmD, MHA, BCOP, is Assistant Professor of Clinical Education at the UNC Eshelman School of Pharmacy. He received his PharmD from Philadelphia College of Pharmacy and completed a PGY1 and PGY2 from UNC Hospitals.

image

Sandra Leal, PharmD, MPH, FAPhA, CDE

Executive Vice President, Health Plan/Payer Business Unit, Tabula Rasa HealthCare

Sandra Leal is the Executive Vice President for the Health Plan/Payer Business Unit for Tabula Rasa HealthCare. Dr. Leal is responsible for oversight and forward-thinking expansion services that focus on improved outcomes, access, and quality.

 Dr. Leal received her PharmD from the University of Colorado and her MPH in Public Health Practice from the University of Massachusetts. Dr. Leal completed her residency at the Southern Arizona VA Health Care System and a Primary Health Care Policy Fellowship with the Department of Health and Human Services. Her work has been published in Diabetes Care, Advances in Chronic Kidney Disease, American Journal of Health-System Pharmacy, Journal of the American Pharmacists Association, Annals of Internal Medicines and a discussion paper published by the Institute of Medicine entitled, “Patients and Health Care Teams Forging Effective Partnerships.”

image

Bhavesh Shah, RPH, BCOP

Senior Director, Specialty and Hematology/Oncology Pharmacy, Boston Medical Center

Bhavesh Shah is the director of specialty and Hematology-Oncology Pharmacy Services at Boston Medical Center in Massachusetts. He earned his bachelors of science in pharmacy at the massachusetts college of pharmacy and health sciences in boston and he is board-certified in oncology pharmacy. He has over 15 years of experience in the field of Hematology/Oncology. At Boston Medical Center he also oversees clinical and specialty resources in Oncology, Transplant, Renal, Cardiology, IBD, Endocrine, Pulmonary, Rheumatology, Neurology, HIV, General Internal medicine, Geriatrics, Anticoagulation etc...) He also manages and oversees specialty pharmacy contracting, limited distribution drug procurement, value based contracting and patient financial assistant programs at Boston Medical Center. His research experience is in cancer-related anorexia and cachexia syndrome, prevention of chemotherapy induced nausea and vomiting, treatment of iron deficiency anemia and various other population health based quality improvement projects.

Closing the Oncology Research Gap: Pharmacy's Role Defined

image

Sandeep Parsad, PharmD, MBA, BCOP (Moderator)

Assistant Pharmacy Director, Cancer & Investigational Drug Services; Director, PGY2 Oncology Pharmacy Residency Program, University of Chicago Medicine

Sandeep Parsad, PharmD, MBA, BCOP, is the assistant director of pharmacy at the University of Chicago Medicine. She is the director of the PGY2 oncology pharmacy residency program, co-chair of the Oncology Drug Safety Committee, and oversees hematology/oncology and investigational drug services.  

Dr. Parsad has a strong interest in stem cell transplantation, hematologic malignancies, value-based payment models, and oncology quality initiatives.

image

Sapna Amin, PharmD, BCOP

Manager, Investigational Pharmacy Services Division of Pharmacy, MD Anderson Cancer Center

Experienced Pharmacy Manager with a demonstrated history of working in the hospital & health care industry. Skilled in Electronic Medical Record (EMR), Management, Clinical Research, Oncology, and Hospitals. Subject matter expert on pharmacy related Investigational Drug/Pharmacy Services.
Experience with Phase 1 clinical trial design, clinical trial logistics, FDA, GCP/CFR, and Pharmacy Regulations. Experience with Phase l-IV clinical trials, IRB regulations, clinical trial conduct, and Pharmacy auditing.
 

image

Cindy L. O'Bryant, PharmD, BCOP, FCCP, FHOPA

Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus

Cindy L. O’Bryant is an Associate Professor with the Department of Clinical Pharmacy at the University of Colorado School Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. O’Bryant serves as the director of the Oncology Pharmacy Residency Program and Co-Director of the Oncology Clinical Research Fellowship. Dr. O’Bryant has served as President of the Hematology/Oncology Pharmacy Association and Chair of the American College of Clinical Pharmacy Hem/Onc PRN. Her current practice is at the University of Colorado Cancer Center in the Developmental Therapeutics (Phase 1)/ GI program where she is currently a principal investigator of Phase 1 clinical trials. Her areas of interest and research include oncology early drug development, organ dysfunction resulting anticancer agent dose modification, and supportive care/education issues in cancer treatment. 

image

Siu Fun Wong, PharmD

Chair, SWOG Pharmaceutical Science Committee

Dr. Siu-Fun Wong, PharmD, is Associate Dean of Assessment and Scholarship, and a Full Professor at Chapman University School of Pharmacy. Dr. Wong joined Western University in 1997 as one of the founding faculty. Dr. Wong is also a volunteer Clinical Professor of Medicine at the University of California, Irvine (UCI) College of Medicine where she teaches anti-cancer pharmacology to the oncology fellows, medical students, and undergraduate students since early 1990s. In 2010, Dr. Wong joined Loma Linda University (LLU) and was appointed Professor of Pharmacotherapy and Outcomes Science at the School of Pharmacy until March of 2013 when she joined Chapman University to assume her current position. During her tenure at LLU, Dr. Wong established an innovative oral chemotherapy management clinic at LLU Cancer Center in 2011 that integrates patient care and outcome research.

Dr. Siu-Fun Wong earned her Bachelor of Science degree in Biochemistry from the University of California, Los Angeles followed by Doctor of Pharmacy degree from the University of California, San Francisco (UCSF) School of Pharmacy. She completed a clinical residency at the University of California, Irvine (UCI) Medical Center where she stayed to develop the oncology pharmacy program and the Infusion Center Pharmacy at the Chao Comprehensive Cancer Center delivering direct patient care and actively engaged in clinical research.

Dr. Wong’s primary research interest is in supportive care in oncology where she conducts studies to optimize the management of adverse events experienced by the cancer patients with the intent to improve patient’s quality-of-life. Her current research theme is in the management of papulopustular skin rash in cancer patients receiving epidermal growth factor receptor (EGFR) inhibitors. She recently completed a study to validate a patient self-reporting Functional Assessment of Cancer Therapy (FACT-EGFR) nationally through SWOG cooperative group. The next phase of the study will be a randomize double-blind clinical study to evaluate the efficacy and safety of a topical cream in the treatment of the skin rash which also includes the translational research component to explore innovative method to obtain dermatologic biospecimens. Dr. Wong also conducts outcomes research to seek for development of best practice model in cancer patient care and advocacy work to improve environmental health in the safe handling and disposal of oral chemotherapy. Dr. Wong brings her expertise in drug development, pharmacotherapy, and outcome research in cancer populations to collaborate with the SWOG investigators and at other inter-professional settings. 

 

ADDITIONAL ACCC HANDOUTS TO SUPPLEMENT YOUR LEARNING 

 

  • ACCC Oncology Pharmacy Education Network—Access Upcoming live and on-demand webinars, needs assessments, educational resources and multidisciplinary connections that advance the field and elevate oncology pharmacy professionals to top-of-license practice. 
     
  • Call for OPEN Task Force MembersWe are seeking a multidisciplinary group of volunteers to serve in various leadership roles, including on the expert advisory committee which leads the initiative, as well as on mission-driven task forces. The deadline to submit your application is Friday, November 5. 
     
  • Multiple Myeloma Dispensing Models Webinar SeriesFeaturing one live webinar on November 4 at 3:00 PM EDT and five on-demand recordings that explore various dispensing models and effective practices in the care of patients with multiple myeloma.    

  • Addressing the needs of older adults with cancer is critical for the delivery of high-quality, patient-centered care. Through the Multidisciplinary Approaches to Caring for Older Adults with Cancer project, ACCC will identify barriers and best practices for serving this growing patient population in order to help support the multidisciplinary team in understanding and proactively preparing for the impact of our graying nation on cancer prevalence and co-morbidity burden.  
  • Explore the resources and tools that are being developed in conjunction with Dr. Oyer’s President’s Theme, “Community Oncology Can Close the Gap in Cancer Research.” This page will be updated regularly as new deliverables become available.  
     
  • ACCC members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, ACCC members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience.  Join the discussion and connect with your peers. 
     
  • Looking to become a member of the Association of Community Cancer Centers? Visit our membership page for more information on the types of membership we offer and how you can become involved. If you’re unsure whether or not you’re already a member, please contact our membership department today. 
     
  • ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today! 

Key:

Complete
Failed
Available
Locked
Pharmacy Metrics for Off-Label Treatment
Session 1: Pharmacy Metrics For Off-Label Treatment
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Anti-cancer treatment plans inclusive of an off-label agent(s) are often more costly for patients and cancer programs. The need for time-intensive prior authorizations, peer-to-peer review, and potential delay in time to treatment initiation are just a few of the challenges cancer care team members face. This session will explore patient and staff impact, effects on program revenue integrity, and suggested metrics to track off-label use.
Session 1: Presentation Slides
Open to download resource.
Open to download resource.
Session 1 Feedback Survey
4 Questions
Pharmacists and Older Adults with Cancer: Effective Practices
Session 2: Pharmacists and Older Adults with Cancer: Effective Practices
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Developing models of care that support older patients is critical in managing chemotherapy treatments and improving outcomes and overall quality of care. Discover how pharmacists play a key role in this equation as they can collaboratively monitor and manage side effects, empirically suggest appropriate dose adjustment(s), and help manage inappropriate polypharmacy.
Session 2: Presentation Slides
Open to download resource.
Open to download resource.
Session 2 Feedback Survey
4 Questions
Billing for Chemotherapy Patient Management: Extending and Elevating the Pharmacist Role
Session 3: Billing for Chemotherapy Patient Management: Extending and Elevating the Pharmacist Role
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. With an increased demand for oncology services, an expanded role for pharmacists as members of the cancer care delivery team is continuing to emerge. Learn how models for pharmacist billing for services such as telehealth medication-related visits, medication therapy care management, and discharge management in the cancer setting can demonstrate additional value of pharmacy services and extend existing care models.
Session 3: Presentation Slides
Open to download resource.
Open to download resource.
Session 3 Feedback Survey
4 Questions
Closing the Oncology Research Gap: Pharmacy's Role Defined
Session 4: Closing the Oncology Research Gap: Pharmacy's Role Defined
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Given low clinical trial enrollment among adult oncology patients and increased work burden for patients on trial, understanding current research responsibilities of pharmacists could lead to identification of opportunities to leverage this workforce to enhance accrual to and conduct of clinical trials. Learn more about resources which already exist, successful models for pharmacist integration into oncology research teams, and the unique skills which pharmacists offer the interdisciplinary team.
Session 4: Presentation Slides
Open to download resource.
Open to download resource.
Session 4 Feedback Survey
4 Questions